ArticleBMC cancer2020

Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience.

Jana Käthe Striefler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.